AIMS Lab

The League of Minnesota Cities is promoting a City Finance Lab, a training programme built around the practical finance needs of cities. The initiative is aimed at helping municipal staff handle budgeting and financial management tasks specific to local government. The announcement is circulating among local government audiences interested in municipal finance education.

Anthropic has rolled out new analytics dashboards for Claude alongside a beta release of its Motion tools, expanding how developers and teams monitor usage and automate workflows. The launch gives enterprise customers better visibility into model performance and spending, while the beta Motion tools aim to streamline task automation. The announcement is drawing attention across the AI industry as competition among major AI labs intensifies.

Lab Manager has published guidance on selecting laboratory technology suited to an organisation's specific requirements. The piece walks readers through evaluating their needs before investing in new lab equipment and systems, a common challenge for laboratories balancing budgets, workflows and technical demands. It is aimed at lab managers and decision-makers weighing up which technologies will deliver the most value for their operations.

Nous Research has confirmed it reached a $1.5 billion valuation and announced the launch of AI agents aimed at business users. The open-source AI startup is expanding beyond research tools into commercial offerings, positioning itself among a wave of AI companies attracting major valuations as enterprises adopt autonomous agent technology.

Anthropic is rolling out free Mythos security scans for open-source developers, positioning AI as the answer to AI-powered hacking. The tool is aimed at helping developers whose code is widely used but often poorly resourced find and fix vulnerabilities before attackers can exploit them. Coverage frames it as an unusual defensive play from an AI lab.

Harvard ageing researcher David Sinclair is developing ER-100, a compound aimed at testing whether biological age reversal in humans is possible. The announcement has drawn attention across science and wellness circles, with commentators weighing the promise of reprogramming-based therapies against long-standing scepticism about Sinclair's bold claims and the long road from lab results to proven treatments in people.

vCluster Labs has announced the release of Stacks, a product designed to package any AI environment as a managed service. The announcement was carried widely across technology and business outlets, including VMBlog, Business Wire and Yahoo Finance. The tool is aimed at simplifying how teams deploy and run AI workloads by turning full environments into managed, repeatable services.

PT Revolution has launched The Climb Lab, a six-week climbing performance program based in South Lake Tahoe. The program, announced via the Tahoe Daily Tribune, is aimed at improving climbers' strength, technique and overall performance. Details on pricing, coaching staff and enrollment have not yet been widely reported, and there is little indication yet of broader public reaction to the launch.

Thomas Jefferson National Accelerator Facility is moving forward with Phase II projects under the Genesis Mission, a US science initiative aimed at accelerating discovery through advanced computing and national laboratory research. The announcement outlines the lab's next-stage work within the programme, drawing attention among physics and science-policy observers tracking how national labs contribute to the effort.

Google Labs has launched a new AI tool designed to help users build browser-based games. The tool, announced through Google's experimental division, aims to lower the barrier to game creation by letting users generate playable web games with AI assistance. Details on features and availability remain limited, but the move fits Google's broader push to expand its AI offerings into creative and consumer-facing tools.

The US government, Google and Meta are joining forces to develop 'virtual cells' — computer models that simulate biological cells digitally. The aim is to let researchers run biology experiments in silico, potentially speeding up drug discovery and basic research without lab work. The collaboration pairs big tech's AI and computing power with public-sector science goals.

The US Department of Energy, the National Institutes of Health, and the Biohub research network have announced a partnership to build foundational datasets for predictive biological models described as 'super intelligence' systems. The collaboration aims to generate large-scale biological data that could underpin advanced AI capable of predicting biological behaviour. Details on funding and scope remain limited, but the pairing of national labs, medical research agencies and philanthropy-backed institutes marks a major push in AI-driven biology.

A new brain-computer interface startup has launched with the stated aim of competing with Merge Labs, the neurotechnology venture backed by OpenAI chief executive Sam Altman. The company, covered by Wired, enters a field where Altman's venture has drawn attention for its ambitions around merging human cognition with artificial intelligence. The launch signals growing investor interest in neurotech as a next frontier in the AI race.

A new neurotechnology startup has launched with the stated aim of competing with Merge Labs, the brain-computer interface company backed by Sam Altman. Details of the new company, including its founders and funding, are sparse so far. The move signals growing competition in the consumer neurotech space, where Altman's venture is among several pursuing brain-computer interfaces.

Reports describe an AI system that can assess a meal's flavor profile and nutritional content from a single photograph. By analyzing the visual characteristics of food, the tool aims to estimate calories, nutrients and taste qualities without lab testing or manual input. The development is drawing interest for potential uses in diet tracking, health apps and nutrition research, though questions remain about its accuracy compared with traditional dietary assessment methods.

A new collaboration is taking sensor technology developed in physics laboratories and adapting it for fusion energy applications. The partnership aims to move lab-proven diagnostic and measurement tools into commercial fusion markets as the sector works toward viable power generation. Details of the specific institutions involved and the extent of the partnership remain limited.

Startup Sabi has raised a $50 million seed round led by Khosla Ventures to develop a brain-computer interface built into an ordinary baseball cap. The company aims to let users interact with AI through a wearable that looks like everyday headwear. The unusually large seed round for a non-invasive neurotech wearable is drawing attention to how far consumer brain-interface technology may be moving beyond lab settings.

A local news roundup in Kewanee, Illinois, pulls together several health stories: efforts to raise awareness of mental illness, special promotions or events at area laboratories, and initiatives aimed at improving birth outcomes. The package highlights ongoing community health efforts, though details on each individual story remain limited beyond the roundup itself.

A new neurotechnology startup has launched with the stated aim of competing with Merge Labs, the brain-computer interface company backed by Sam Altman. The venture, covered by Wired, enters a field where Altman's company is pursuing mind-machine interfaces alongside rivals like Neuralink. Details on the startup's founders, funding and technology remain limited, but its arrival signals growing investor interest in neurotech.

Google, Meta and US researchers are building large biological datasets to support 'virtual cells' — computational models of how cells behave. The aim is to let scientists simulate and study cellular processes digitally instead of relying solely on lab experiments. The initiative is drawing attention as one of the most ambitious efforts to combine artificial intelligence with fundamental biological research.

Mistral has released a new open-weight model called Le Chonk aimed at AI-powered cybersecurity, letting businesses run the defense tool themselves while keeping control over their data and deployments. The model arrives as companies look for accessible ways to counter a growing wave of breaches involving AI agents, with open models positioning themselves as an everyman alternative to closed vendor solutions.

Researchers have developed a patient-derived organoid platform for glioblastoma, allowing lab-grown replicas of individual brain tumors to be tested against radiation and drug therapies. The approach aims to reveal how a patient's specific tumor responds to treatment before clinical decisions are made, in a cancer where options remain limited and prognosis is typically poor.